HIV

GSK says it is within weeks of resubmitting HIV injection Cabenuva

By
1 Mins read
177
0
Share
Reading Time: < 1 minute

GlaxoSmithKline’s HIV business ViiV is within weeks of resubmitting its request for approval of its long-acting injection Cabenuva Read More

177
0
Share
Related posts
HIV

HIV, pregnancy, violence: The three-pronged crisis stealing the future of Africa's girls

By
1 Mins read
Reading Time: < 1 minuteMs Abigael* is not just a statistic. She is a young woman navigating three immediate threats to her life:  the risk of…
HIV

Zambia Must Decide Today: Open Minerals To American Firms Or Lose HIV Support For 1.3 Million

By
1 Mins read
Reading Time: < 1 minuteZambia must choose between granting US mineral access or losing crucial HIV treatment funding. Read More
HIV

Man cured of HIV through groundbreaking transplant from his brother in first-of-its-kind procedure

By
1 Mins read
Reading Time: < 1 minuteA man living with HIV has been cured of the devastating disease in a pioneering transplant, doctors have revealed. Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.